Titan Pharmaceuticals
TTNPTitan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA developing proprietary therapeutics primarily for the treatment of central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceed …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Titan Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/21/2023 | Sell | Lazar, David E. | Chief Executive Officer | $1.2 | $9,220,000 |
| 1/25/2023 | Buy | Lazar, David E. | Chief Executive Officer | $1.0 | $20,066 |
| 1/24/2023 | Buy | Lazar, David E. | Chief Executive Officer | $1.0 | $36,221 |
| 7/7/2022 | Buy | Lazar, David E. | Ten Percent Owner | $1.0 | $739,010 |
| 7/6/2022 | Buy | Lazar, David E. | Ten Percent Owner | $0.8 | $1,183,873 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)